|
May 9
|
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
|
|
May 7
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
May 6
|
Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock continues to impress, up 5.0% over last week
|
|
Apr 23
|
Health Care Roundup: Market Talk
|
|
Apr 13
|
Could This Stock Be the Next Biotech Buyout?
|
|
Apr 12
|
Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...
|
|
Apr 11
|
Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
|
|
Apr 5
|
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
|
|
Apr 2
|
Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
|
|
Mar 20
|
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
|
|
Feb 2
|
Vera Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
|
|
Feb 1
|
Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
|
|
Jan 30
|
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
|
|
Jan 12
|
Why Vera Therapeutics Stock Soared by 22% This Week
|
|
Jan 1
|
Pleasing Signs As A Number Of Insiders Buy Vera Therapeutics Stock
|
|
Dec 27
|
Vera Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Nov 14
|
Wall Street Analysts Believe Vera Therapeutics, Inc. (VERA) Could Rally 86.76%: Here's is How to Trade
|
|
Aug 10
|
Vera Therapeutics Provides Business Update and Reports Second Quarter Financial Results
|
|
Aug 4
|
Apogee Therapeutics, Turnstone Biologics, and More Stocks See Action From Activist Investors
|
|
Jun 27
|
Vera Therapeutics Likely Needs Time to Digest Its Recent Dramatic Gains
|